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Introduction
Because of several well-established factors such as a) subjectivity involved in human decision-making, b) domain knowledge, and c) prior experience, 1, 2 there is a possibility of type-1 and type-2 errors in identifying whether patients satisfy a known set of inclusion and exclusion criteria. Furthermore, clinicians typically rely on patterns learnt from patients encountered in their own settings, thereby missing out on the advantage of screening patients or diagnosing them based on latent knowledge and patterns present across an entire health system. An automated process for prescreening and early diagnosis would be quicker and serve as an independent judge. Rare or orphan diseases defined by the Rare Diseases Act of 2002 as diseases that affect fewer than 200,000 people in the United States (equivalent to approximately 6.5 patients per 10,000 inhabitants 3 ) present a special case of this. There are about 8,000 rare diseases such as cardiac amyloidosis today and they appear early in life often proving to be fatal or chronically debilitating. 4, 5 Cardiac amyloidosis is caused by abnormal deposits of protein called amyloid in the heart tissue. 6 These tissues make it hard for the heart to work properly. It is very difficult to successfully recognize a potential cardiac amyloidosis patient manually among large number of other patients. For enrolling rare disease patients for clinical trials, clinicians usually assign pre-defined constraints to filter out most negative patients. However, they still have to manually go through the remaining large part of each patient's medical record to precisely arrive at a correct decision. For decision making, clinicians have a higher chance of missing the diagnosis of a rare disease since the symptoms are largely unknown for many rare diseases and such patients are encountered only a few times during normal care.
The creation and adoption of electronic health records (EHRs) ignited widespread interest and created abundant opportunities for clinical and translational research. 7 As Friedman et al noted, the extensive use of clinical data provides great potential to transform our healthcare system into a "Self-learning Health System." 8, 9 In addition to its primary purpose of providing improved clinical practice, the use of EHRs offers means for the identification of participants who satisfy predefined criteria. This can be used for a variety of applications, including clinical trial recruitment, outcome prediction, survival analysis, and other retrospective studies. [10] [11] [12] [13] The overall goal of this research is to develop a platform that identifies patients potentially with any rare disease or has the risk of any risk disease. We are testing this approach initially on cardiac amyloidosis; however, our approach is scalable to all rare diseases. The main components of our platform are to represent each patient as a multidimensional vector and then to use machine-learning algorithms based on available data on rare diseases to automatically identify them. Figure 1 describes the architecture of our approach. First, we created a reasonable sized dataset of positive and negative cardiac amyloidosis patients using information from past and ongoing clinical trials of cardiac amyloidosis at Northwestern Medicine. A total of 73 cardiac amyloidosis patients were identified and formed the positive instances. A random sample of 197 patients that visited cardiologists at Northwestern Medicine but were not diagnosed to have cardiac amyloidosis (based on their ICD-9 codes) formed the negative instances. The negative patients were chosen in such a way so as to maintain similarity with the positive patients but not have cardiac amyloidosis. A total of 270 patients formed our training dataset as summarized in Table 1 . Negative cardiac amyloidosis patients 197
Methods

Total 270
Next, we represented each patient as a vector using information from their EHRs stored in Northwestern Medicine Enterprise Data warehouse (NMEDW). Each patient record was then processed so that all relevant sections of the patient records which are potentially useful for creating features space were extracted. The relevant sections or feature types we have considered in this study are Demographics (such as Gender, Race, Ethnicity and Age), Diagnosis, Medication, Problems, Surgical data and Progress Notes. Demographics, Diagnosis and Medication, Problems and Surgical data are available in structured form, whereas Progress notes are only available as unstructured text. The value of each feature type is then transformed in order to be useful for machine learning classifier. Each value of Demographics, Diagnosis and Medication is treated as a binary feature. For example, if a patient has diagnosis "Anemia", we assigned a vector for "Anemia" and assigned a value of 1 for that patient and 0 for other patients. Similarly the presence of each medication such "Paracetamol" is treated as a separate feature. Certain variable such as 'age' in Demographics are numeric with a wide range of values. Such features are discretized 14 by transforming the numbers to assignment in bins or ranges. That is, rather than representing the age of the patient by its numeric value (for e.g. 43), we represent it by a range (e.g. [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . Processing the records this way generated, 15 Demographics features, 5002 Diagnosis features, 3521 Medication features, 2124 Problem features and 101 Surgical data features. For transforming Progress notes to informative features, we follow the widely used Bag-of-Words model. The progress notes from all patient records are first preprocessed (lowercase, removal of punctuation and stop words, normalizing numeric values to placeholders) and then tokenized to unigrams and bigrams bag of words. These are then further pruned by ignoring the very high frequency unigrams or bigrams. After the transformation, in total, we get 1766 unigram features and 1044 bigram features for this dataset. The features are summarized in Table 2 . 
Total 13573
On this dataset of 223 instances and 8011 features several machine learning classifiers which we describe next are trained.
The machine learning classification algorithms we have considered in our study are K Nearest Neighbors, 15, 16 Support Vector Machines, 17, 18 Decision Trees, 19 Random Forests, 20 AdaBoost, 21 and Naïve Bayes 22, 23 . K-nearest neighbors (KNN) is an instance based learning algorithm that stores all the training instances and classifies the new cases based on the distance functions. K-NN works on the principle of classifying the new test case by a majority vote, with the test case being assigned to the class most common amongst its K nearest neighbors. Each point in the neighborhood may be assigned equal importance or given some sort of weight such as distance (larger the distance smaller the weight/importance).
Support Vector Machine (SVM) performs classification by finding the hyperplane that maximizes the margin between the two classes. The instances that define the hyperplane are called support vectors. SVM is high performing machine learning classifier due to the fact that if the data is linearly separable, SVM would produce a hyperplane that completely separates the vectors into two classes. However, in real life scenario perfect separation may not be possible. In such a case we can use different kernel function to project the data point into a different feature space where data may be linearly separable. Kernel function can be viewed as feature extraction techniques which take the existing features as input, performs the transformation and output a new feature space. Naïve Bayes (NB) algorithm is based on the Bayes theorem with assumption that the features are independent of each other. NB model is easy to develop with no parameter estimation. Despite its simplicity, NB model is widely used and outperforms other sophisticated machine learning algorithms such as SVM. NB provides a method of calculating posterior probability of class given the prior probability and learning the likelihood of features given the class.
Decision trees (DT) builds classification models using a tree like structure. It works on the principle of divide and conquer breaking the dataset at each feature according to the best split and at the same time incrementally building the tree. The final result of the algorithm is a tree with decision node and leaf nodes. Decision node makes a certain conclusion depending upon the feature and has two or more branches. Leaf node does the final classification.
Random Forest (RF) and AdaBoost are two ensemble algorithms which we have also used in our experiments. The principle behind working of RF algorithm is to construct many decision trees during the training and classifies the test case based on the mode of the classes given by individual trees. AdaBoost is another ensemble methods in which various other machine learning classifiers or also weak learners are combined to give a weighted sum that represents the output of the final classifier. It begins by fitting a classifier first on the data and then learning more classifiers by adjusting the weights of the previously misclassified data points.
In addition, there are also a variety of hyper-parameters that were tuned in tandem for each of these classification algorithms. Table 3 lists the various algorithms and the corresponding hyper-parameters and their value ranges involved with each algorithm. We perform grid search 24 technique which is a brute-force exhaustive method to search for the best parameters through the manually specified subset of the hyper-parameter space of a learning algorithm. Table 3 In addition to various algorithms and models, we also employed feature selection methods to improve upon the accuracy of the classification models. First, features with very low variance are removed. That is, the features whose 85% of values are either '0' or '1' are removed since they do not give much information about either category. We then used L1 regularization 25 to do more feature selection and thereby identify top features to identify those that play decisive roles in classifying the patient into each category. L1 regularization adds a weight penalty to the loss function. Since each non-zero weight adds to the penalty, it forces weak features to have zero weight. Thus, this produces a sparse solution by intrinsically performing feature selection.
To evaluate the system, we perform tenfold cross-validation and report the average F1 score 26 (harmonic mean of precision and recall). Table 4 shows the optimal configuration for each classification algorithm used as measured by average tenfold cross-validation F1 score. Since the number of positive instances in the dataset is very small, the number of nearest neighbors (KNN) take the least possible value 1 (K in KNN). KNN and NB gives a very low F1 score as compared to other complex algorithms since they are sensitive to outliers and also do not perform adequate feature selection. These algorithms give equal importance to all the features, which leads to poor performance. On the other hand, SVM, DT and Ensemble methods give a large F1-score due to complexity in models and ability to intrinsically performing feature selection. Also, as expected, ensemble method AdaBoost outperforms rest of the algorithms since it combines the output of other weak learners to arrive at the final hypothesis. We list some of the important features obtained after performing feature selection in Table 5 . It can be seen that patients in age range 70-90 are more likely to have cardiac amyloidosis than patients of other ages. Also, presence of other cardiac diagnosis such as congestive heart failure and chest pain as important features shows that cardiac amyloidosis are comorbid with other heart problems. Some of the medications are also suggestive of this hypothesis. However, this requires further analysis and inputs from multiple cardiologists.
Results
The accuracy measures on re-running the machine learning algorithms using only the features filtered from feature selection technique are listed in Table 6 . All the algorithms give nearly high and similar average cross-validation F1 score. As anticipated, there is also rise in scores of KNN and NB due to removal of noisy insignificant features. 
Discussion
This work is very relevant to an emerging direction in clinical informatics research focusing on developing patient similarity measures derived from EHR data for application in a variety of areas. [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] For example, Zhang et al used patient similarity and drug similarity for personalized medicine. 35 Wang et al attempted to implement treatment recommendations and Sanders et al used similarity measure for visualizing which patients are similar. 27, 28 Li et al used topological similarity measures to identify subgroups of type 2 diabetes patients. 31 Huang et al applied such metrics for analyzing clinical pathways and Lee et al and Ng et al applied for predicting mortality for individual patients. 32, 36 There are systems such as PSF that are evaluating novel metric learning approaches and those that are using external knowledge resources such as PubMed to improved patient similarity measures. 33, 34 We also used Apache cTAKES 37 to extract more features from unstructured Progress notes. However, since we are already accomplishing a very high average cross-validation F1 score and the unigram and bigram features that are also obtained from progress notes are not very predictive, we decided not to currently use them in further experiments. These would have only further escalated the curse of dimensionality 38 and will not have contributed significantly to increase the accuracy of the models. However, we might implement NLP-based features as we are expanding our algorithm to other rare diseases.
In spite of the high accuracy of our system, there is a limitation. In our training set, the instances are moderately balanced, i.e., positive and negative instances are 1:3 in ratio. However, as we have mentioned in the Introduction, cardiac amyloidosis is a rare disease. The ratio in real scenario will be closer to 1:1000. If we directly use the models produced through our methods, we may get a large number of false positives and thereby low precision rate because of failure to generalize and the sample data not being true representative of real world data 39 . To counter this, we need to do preprocessing using high recall rules to filter out the very obvious negative instances. The goal of these rules will be to reduce the skewness of the real world data. After the filtering step, our models can be applied on the resulting dataset. These high recall rules can be implemented using the factors identified through our methods as most predictive in Table 5 . We can also employ other feature selection techniques such as wrapper methods, tree based induction methods 40 or use association mining 41, 42 for doing. We consider this beyond the scope of this initial work.
Conclusion
We have developed a machine learning system to automatically identify cardiac amyloidosis patients using EHR data. We performed data processing, parameter estimation, feature selection and model selection to achieve a very high tenfold cross-validation F1 score of 0.98 using Random Forest, an ensemble machine learning classifier. We have also reported some of the most predictive features. However, our system needs to be validated for its operational value across an entire healthcare system by executing it on system-wide EHR data for identifying rare disease patients and manually verifying the accuracy.
